# US 2012/0251468 A1 · Compositions Comprising Alginates with High Guluronic Acid/Mannuronic Acid Ratio for use in the Treatment of Dentine Hypersensitivity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251468 A1
- Document ID: US20120251468A1
- Status: Published application
- Kind: A1
- Application number: 13/515,415
- Filed: 2010-12-15
- Published: 2012-10-04
- Earliest claimed: 2009-12-17
- Assignees: Glaxo Group Limited
- Inventors: Charles Richard Parkinson
- Web page: https://patentgrep.com/patent/US20120251468A1

## CPC

- A61K 8/733: {Alginic acid; Salts thereof}
- A61K 31/734: Alginic acid
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to oral care compositions comprising certain alginates for the treatment of dentine hypersensitivity and to their use.

## Claims

### Claim 1

An oral care composition comprising an alginate having a ratio of α-L-guluronic acid to β-D-mannuronic of higher than 1.0:1.0 for use in treating dentine hypersensitivity.

### Claim 2 (depends on 1)

An oral care composition according to claim 1 wherein the alginate has a ratio of α-L-guluronic acid to β-D-mannuronic of about 1.2:1.0 to 1.8:1.0.

### Claim 3 (depends on 1)

An oral care composition according to claim 1 wherein the alginate has a ratio of α-L-guluronic acid to β-D-mannuronic of about 1.4:1.0 to 1.8:1.0.

### Claim 4 (depends on 1)

An oral care composition according to claim 1 wherein the alginate comprises a viscosity in the range 1 to 100 cP when measured as a 1% w/w solution in water at 37° C. on a Brookfield viscometer.

### Claim 5 (depends on 1)

An oral care composition according to claim 1 wherein the alginate is selected form Manugel LBA, Manugel DMB or mixtures thereof.

### Claim 6 (depends on 1)

An oral care composition according to claim 1 wherein the alginate is Manugel LBA.

### Claim 7 (depends on 1)

An oral care composition according to claim 1 wherein the alginate is present in an amount from about 0.5% wt to about 6% wt of the composition.

### Claim 8 (depends on 1)

An oral care composition according to claim 1 in the form of a mouthwash.

### Claim 9 (depends on 1)

A process for the preparation of an oral care composition according to claim 1 which process comprises admixing the ingredients thereof in the required proportions in any order that is convenient.

### Claim 10 (depends on 1)

A method for treatment of dentine hypersensitivity which comprises applying an effective amount of a composition as defined in claim 1 to an individual in need thereof.
